Massachusetts Medical Society: Annual Education Program: COVID-19: What do we know and how does that help?

Annual Education Program: COVID-19: What do we know and how does that help?

COVID-19 - What do we know and how does that help?

View the 2020 Annual Education Program without CME.

Video Only

To earn CME, proceed to the bottom and choose the purchase button.

Course Overview

The 2020 Massachusetts Medical Society Annual Education Program (held May 30, 2020) addresses what we know about COVID-19 and how this helps. This is an exceptional opportunity to learn from Eric J. Rubin, MD, PhD, Editor-in-Chief, The New England Journal of Medicine and moderator Rochelle P. Walensky, MD, MPH, Chief of Infectious Diseases at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School.  Drs. Rubin and Walensky assess the evidence for current medical therapies for COVID-19, examine the risk and benefits of utilizing investigational medications to prevent or treat COVID-19, and discuss the issues in developing vaccines for COVID-19.  


Eric J. Rubin, MD, PhD

Eric J. Rubin, MD, PhD
Editor-in-Chief, The New England Journal of Medicine, NEJM Group

Eric J. Rubin, M.D., Ph.D., joined the New England Journal of Medicine (NEJM) and NEJM Group as Editor-in-Chief in September 2019, taking on the responsibility for oversight of all editorial content and policies.

Dr. Rubin is an Associate Physician specializing in infectious disease at Brigham and Women’s Hospital and is the Chair and Irene Heinz Given Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health.

Dr. Rubin’s research focuses on tuberculosis, its pathogenesis, and interventions that can help treat and prevent the disease. Collaborating widely across the broad TB research community, his lab has developed many of the genetic tools that are used to study the causative organism, Mycobacterium tuberculosis, and has employed them to understand the molecular mechanisms underlying virulence and susceptibility and resistance to antibiotics.

Dr. Rubin serves on several scientific advisory boards to groups interested in infectious disease therapeutics, among them the Global Alliance for TB Drug Development, the Structure-Guided Drug Development Consortium, and the Sub-Saharan African Network for TB/HIV Research Excellence at the KwaZulu-Natal Research Institute for TB-HIV. He has also previously served as the Associate Editor for Infectious Disease at the New England Journal of Medicine and as an editor for several basic science journals, including PLoS Pathogens, Tuberculosis, and Current Opinion in Microbiology.

Rochelle Walensky

Rochelle P. Walensky, MD, MPH

Professor of Medicine, Chief, Division of Infectious Diseases, MGH, Steve and Deborah Gorlin MGH Research Scholar

Rochelle Walensky, MD, MPH, is the Chief of Infectious Diseases at MGH and Professor of Medicine at Harvard Medical School. Dr. Walensky’s research interests have focused on HIV/AIDS policy and cost-effective strategies of HIV care in the US and in resource-limited settings; she is internationally recognized for motivating US and global policy toward routine HIV screening. She is a member of the American Society for Clinical Investigation, the American Association of Physicians, and the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, and she is past Chair of the NIH Office of AIDS Research Advisory Council. She has also been an advisor to the WHO and UNAIDS. Dr. Walensky received her M.D. from the Johns Hopkins School of Medicine and her M.P.H. from the Harvard School of Public Health. She trained in Internal Medicine at the Johns Hopkins Hospital and in Infectious Diseases at the MGH/BWH combined fellowship program. She is married to a physician scientist and the mother of 3 boys, ages 16, 18 and 20.

Course Objectives

  • Assess the evidence for current medical therapies for COVID-19
  • Examine the risk and benefits of utilizing investigational medications to prevent or treat COVID-19
  • Discuss the issues in developing vaccines for COVID-19

Course Fees

MMS Member Physician: Free
MMS Resident/Student Member: Free
Non-MMS Member Physician: Free
Allied Health Professional: Free

Format and Estimated Time to Complete

Video, 1 hour

Accreditation & Credit Information

Accreditation Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

AMA Credit Designation Statement
The Massachusetts Medical Society designates this internet enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Approval Statement 
Through the American Board of Medical Specialties ("ABMS") ongoing commitment to increase access to practice relevant Maintenance of Certification ("MOC") Activities through the ABMS Continuing Certification Directory , this activity has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

Allergy and Immunology
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Thoracic Surgery

National Commission on Certification of Physicians Assistant (NCCPA)
Physician Assistants may claim a maximum of 1.00 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

You must complete the assessment at the end of the course to receive AMA PRA Category 1 Credit™.

Activity Term

Original Release Date: June 9, 2020
Review Date (s): N/A
Termination Date: June 9, 2023

Course Developers, Reviewers & Web Producer

Jane E. Gagne, Manager, Accreditation & Education Compliance, NEJM Group Education
Vanessa P. Kenealy, JD, Public Health & Preparedness Programs Specialist, Massachusetts Medical Society
Danna G. Muir, Director, Accreditation & Recognition, NEJM Group Education
Thelma Tatten, Web Content Production Specialist, NEJM Group Education
Susan Webb, Director Health Policy & Public Health, Massachusetts Medical Society

System Requirements

Windows 10
Mac OSX 10.6 higher

Most modern browsers including:  
IE 11+
Firefox 18.0+
Chrome latest version
Safari 12+

iOS devices beginning with OS version 10 or higher (includes, iPhone, ipad and iTouch devices) 

Facebook logoLinkedInYouTube logoInstagram

Copyright © 2024. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or